Elwyn Specialty Care

2
Mar

Elwyn Specialty Care Pharmacy Selected by Sanofi Genzyme to Distribute AUBAGIO® (teriflunomide)

Being selected By Sanofi Genzyme demonstrates Elwyn Specialty Care Pharmacy’s ability to provide the highest level of service as a specialty pharmacy serving patients, prescribers, and payers in the specialty Multiple Sclerosis (MS) space

On March 2nd, 2017, Elwyn Specialty Care, a specialty pharmacy which is part of the Elwyn Pharmacy Group announced that it was been selected by Sanofi Genzyne as one of the limited group of specialty pharmacies authorized to distribute one of the manufacturer’s Multiple Sclerosis drugs—AUBAGIO® (teriflunomide). As a result of being added to this exclusive network, Elwyn Specialty Care is recognized as part of an elite limited group and is one of the only independently owned and operated specialty pharmacy’s included in the network.

AUBAGIO is a once-daily pill used to treat relapsing forms of MS that has been shown to quiet MS. AUBAGIO® (teriflunomide) is effective across key measures of disease activity: sustained disability progression (14 mg only), annualized relapse rate, and MRI activity in MS patients

“At Elwyn Specialty Care we are pleased and excited to be one of the few independent specialty pharmacies accepted into this exclusive network.  Providing services to the specialty Multiple Sclerosis patients has been a passion of ours since we established our specialty pharmacy years ago. It is one of the reasons why we exist today and why we established our mission and vision as a specialty pharmacy.  We feel honored to be chosen and included as part of the network”.  (“Our goal is to achieve optimal patient outcomes through compliance and delivery of individualized medication therapy management in an environment that maximizes patient satisfaction and adherence”) says Nicholas Karalis, RPh, President CEO at Elwyn Pharmacy Group

 

About Elwyn Specialty Care Also Part of The Elwyn Pharmacy Group:
At Elwyn Specialty Care we provide medications, under a comprehensive umbrella of medication therapy management, to people living with many complex disease states. We understand the complexity of managing patients’ medication and that treatment paradigms vary greatly and are highly individualized. Our patient-centered approach enables us to adapt and customize a collaborative medication therapy management plan for every patient.  It is our goal to ensure treatment success and patient safety with the highest level of focus, care and compassion possible.

Elwyn Specialty Care is part of the Elwyn Pharmacy Group and provides a complete range of specialty pharmacy and infusion services.   We treat a wide array of complex disease states such as Multiple Sclerosis, Hepatitis C and other GI related diseases, Oncology/Cancer, bleeding disorders, Rheumatoid Arthritis, Psoriasis and HIV. Elwyn Specialty Care, a privately-held, pharmacist-owned company located in Garnet Valley, PA, is accredited by URAC, and the Accreditation Commission for Health Care (ACHC). For more information about Elwyn Specialty Care or Elwyn Pharmacy Group please contact us at 1-855-ELWYN-RX (359-9679) or visit us on the web at www.elwynspecialtycare.com or www.elwynpharmacygroup.com

16
Feb

Elwyn Specialty Care now approved provider for Health Partners Plans

Elwyn Specialty Care is pleased to announce that they are an approved provider for Health Partners Plans to provide Specialty Pharmacy and Infusion Services for your patients. The Elwyn Specialty Care service offering includes:

• Independently Owned & Operated
• Open 7 days/week, 365 days/year
• Dedicated Disease Specific Management Teams
• Reimbursement and Coordination of Benefits
• Outcome Data Collection and Reporting
• Scheduled Compliance Calls with your Patients
• Comprehensive Disease Management Assistance
• Prior Authorization Assistance
• Compassionate Customer Service Specialists
• Copay and Foundation Program Assistance
• Access to Limited Distribution Medication
• Comprehensive Inventory to Ensure Timely Prescription Filling

16
Feb

Elwyn Specialty Care now approved provider for Perform RX

Elwyn Specialty Care is pleased to announce that they are an approved provider for Perform RX to provide Specialty Pharmacy and Infusion Services for your patients.The Elwyn Specialty Care service offering includes:

• Independently Owned & Operated
• Open 7 days/week, 365 days/year
• Dedicated Disease Specific Management Teams
• Reimbursement and Coordination of Benefits
• Outcome Data Collection and Reporting
• Scheduled Compliance Calls with your Patients
• Comprehensive Disease Management Assistance
• Prior Authorization Assistance
• Compassionate Customer Service Specialists
• Copay and Foundation Program Assistance
• Access to Limited Distribution Medication
• Comprehensive Inventory to Ensure Timely Prescription Filling

16
Feb

Elwyn Specialty Care now approved specialty pharmacy in the Department of Defense, T-Pharm Tri-Care Program

Elwyn Specialty Care is pleased to announce that we are now an approved specialty pharmacy in the Department of Defense, T-Pharm Tri-Care Program. We are dedicated to giving the best services possible to all military members and their families. The Elwyn Specialty Care service offering includes:

• Independently Owned & Operated
• Open 7 days/week, 365 days/year
• Dedicated Disease Specific Management Teams
• Reimbursement and Coordination of Benefits
• Outcome Data Collection and Reporting
• Scheduled Compliance Calls with your Patients
• Comprehensive Disease Management Assistance
• Prior Authorization Assistance
• Compassionate Customer Service Specialists
• Copay and Foundation Program Assistance
• Access to Limited Distribution Medication
• Comprehensive Inventory to Ensure Timely Prescription Filling

16
Feb

Elwyn Specialty Care now approved provider for Aetna

Elwyn Specialty Care is pleased to announce that they are an approved provider for Aetna to provide Specialty Pharmacy and Infusion Services for your patients. The Elwyn Specialty Care service offering includes:

• Independently Owned & Operated
• Open 7 days/week, 365 days/year
• Dedicated Disease Specific Management Teams
• Reimbursement and Coordination of Benefits
• Outcome Data Collection and Reporting
• Scheduled Compliance Calls with your Patients
• Comprehensive Disease Management Assistance
• Prior Authorization Assistance
• Compassionate Customer Service Specialists
• Copay and Foundation Program Assistance
• Access to Limited Distribution Medication
• Comprehensive Inventory to Ensure Timely Prescription Filling

16
Feb

Elwyn Specialty Care now approved provider for Horizon Blue Cross Blue Shield of New Jersey

Elwyn Specialty Care is pleased to announce that they are an approved provider for Horizon Blue Cross Blue Shield of New Jersey to provide Specialty Pharmacy and Infusion Services for your patients. The Elwyn Specialty Care service offering includes:

• Independently Owned & Operated
• Open 7 days/week, 365 days/year
• Dedicated Disease Specific Management Teams
• Reimbursement and Coordination of Benefits
• Outcome Data Collection and Reporting
• Scheduled Compliance Calls with your Patients
• Comprehensive Disease Management Assistance
• Prior Authorization Assistance
• Compassionate Customer Service Specialists
• Copay and Foundation Program Assistance
• Access to Limited Distribution Medication
• Comprehensive Inventory to Ensure Timely Prescription Filling

18
Jan

Elwyn Specialty Care announces the addition of Jud Hall as Vice President of Infusion Services

Jud Hall

Elwyn Specialty Care is excited to announce the addition of Jud Hall to its team as Vice President of Infusion Services.  Jud brings a wealth of experience and knowledge as experienced leader in IG/Hemophilia.  As a company we set out with the goal in 2015 to expand in the area of IG as well as Hemophilia.  To assist in this expansion we set out to locate and bring on an experienced leader to build and support a national sales force as well as assist operationally on both the manufacturer and payer side as well.  Jud is extremely well known and respected in the IG/Hemophilia space.  He has taken many companies from humble beginnings to large extremely well know large infusion providers.

His career and experience in Infusion Services began At Premier Infusion. After learning the business, Premier was acquired by Carepoint Partners where he helped build and establish a successful, well run organization.  In 2012 Carepoint partners was acquired by Bioscrip where he most recently continued to build a national platform company and further expand the Infusion Services business development area. We are excited to have him as part of the Elwyn Family.

2
Mar

Elwyn Specialty Care Pharmacy Selected by Bayer HealthCare to Distribute Nexavar and Stivarga

Being selected By Bayer Healthcare demonstrates Elwyn Specialty Care Pharmacy’s ability to provide the highest level of service as a specialty pharmacy serving patients, prescribers, and payers in the specialty oncology space.

On March 2nd, 2015, Elwyn Specialty Care, a specialty pharmacy which is part of the Elwyn Pharmacy Group announced that it was been selected by Bayer HealthCare as one of the limited group of specialty pharmacies authorized to distribute two of the manufacturer’s oral oncology drugs—Nexavar® (sorafenib) and Stivarga® (regorafenib). As a result of being added to this exclusive network Elwyn Specialty Care is recognized as part of an elite limited group and is one of the only independently owned and operated specialty pharmacy’s included in the network.

Nexavar is an oral medication used to treat certain cancers of the thyroid, kidney and liver. In fact, the latest FDA indication is the first and only medication used to treat late-stage (metastatic) differentiated thyroid cancer, which is progressing and can no longer be treated with radioactive iodine treatment. The FDA approved Nexavar to treat advanced kidney cancer in 2005. In 2007, the agency expanded the drug’s label to treat liver cancer that cannot be surgically removed, and in late 2013, the drug was further approved to treat metastatic differentiated thyroid cancer.

Stivarga is also an oral medication used to treat a variety of gastrointestinal cancers that have spread to other parts of the body, in patients who have previously received treatment with other specific chemotherapy agents. According to the Centers for Disease Control and Prevention, colorectal cancer is the third most common cancer in men and in women and the third leading cause of cancer death in men and in women in the United States. Stivarga was approved by the FDA for this indication in 2012.

“At Elwyn Specialty Care we are pleased and excited to be one of the few independent specialty pharmacies accepted into this exclusive network.  Providing services to the specialty oncology patients has been a passion of ours since we established our specialty pharmacy years ago. It is one of the reasons why we exist today and why we established our mission and vision as a specialty pharmacy.  We feel honored to be chosen and included as part of the network”.  (“Our goal is to achieve optimal patient outcomes through compliance and delivery of individualized medication therapy management in an environment that maximizes patient satisfaction and adherence”) says Nicholas Karalis, RPh, President CEO at Elwyn Pharmacy Group

 

About Elwyn Specialty Care also Part of The Elwyn Pharmacy Group:
At Elwyn Specialty Care we provide medications, under a comprehensive umbrella of medication therapy management, to people living with many complex disease states. We understand the complexity of managing patients’ medication and that treatment paradigms vary greatly and are highly individualized. Our patient-centered approach enables us to adapt and customize a collaborative medication therapy management plan for every patient.  It is our goal to ensure treatment success and patient safety with the highest level of focus, care and compassion possible.

Elwyn Specialty Care is part of the Elwyn Pharmacy Group and provides a complete range of specialty pharmacy and infusion services.   We treat a wide array of complex disease states such as Hepatitis C, Oncology/Cancer, bleeding disorders, Rheumatoid Arthritis, Psoriasis. Elwyn Specialty Care, a privately-held, pharmacist-owned company located in Garnet Valley, PA, is accredited by URAC, and the Accreditation Commission for Health Care (ACHC). For more information about Elwyn Specialty Care or Elwyn Pharmacy Group please contact us at 1-855-ELWYN-RX (359-9679) or visit us on the web at www.elwynspecialtycare.com or www.elwynpharmacygroup.com

1
Feb

Elwyn Specialty Care Pharmacy Earns URAC Accreditation

Accreditation by URAC demonstrates Elwyn Specialty Care Pharmacy’s ongoing commitment to the highest level of quality as a specialty pharmacy serving patients, prescribers, and payers.

Elwyn Specialty Care Pharmacy which is part of the Elwyn Pharmacy Group, announces today that URAC, the largest accrediting body for health care, has given its seal of approval by accrediting it through a rigorous on-site process.  This most recent accreditation from URAC adds to a prestigious list of accreditations that Elwyn Specialty Care already maintains, including accreditation from ACHC.

It is an honor to achieve full URAC accreditation at Elwyn Specialty Care.  This accreditation displays our commitment to quality and excellence in providing the highest level of customer service possible to our patients and referral sources.  We are so proud of our Elwyn Specialty Care team members for their hard work and dedication to our mission which made this monumental task a reality (“Our goal is to achieve optimal patient outcomes through compliance and delivery of individualized medication therapy management in an environment that maximizes patient satisfaction and adherence”) says Nicholas Karalis, RPh, President CEO at Elwyn Pharmacy Group

URAC, the industry leader for health care accreditation, is an independent, nonprofit organization that provides benchmarking services throughout the health care system. The URAC accreditation process included a review of all of Elwyn Specialty Care’s policies and procedures as well as an onsite visit to confirm that the operations at Elwyn Specialty Care do, in fact, conform to all documented submitted policies and procedures. A committee of health care experts developed the URAC standards, which are updated every three years.

Since URAC is independent accrediting body patients, referral sources as well as other customers can feel confident that the accreditation process is impartial and not influenced by any other outside industry interests. Accreditation from URAC serves as a symbol of excellence and demonstrates to patients, providers, and insurance payers that Elwyn Specialty Care as an independently owned and operated company is committed to operating at strict quality standards.

About Elwyn Specialty Care also Part of The Elwyn Pharmacy Group:
At Elwyn Specialty Care we provide medications, under a comprehensive umbrella of medication therapy management, to people living with many complex disease states. We understand the complexity of managing patients’ medication and that treatment paradigms vary greatly and are highly individualized. Our patient-centered approach enables us to adapt and customize a collaborative medication therapy management plan for every patient.  It is our goal to ensure treatment success and patient safety with the highest level of focus, care and compassion possible.

Elwyn Specialty Care is part of the Elwyn Pharmacy Group and provides a complete range of specialty pharmacy and infusion services.   We treat a wide array of complex disease states such as Hepatitis C, Oncology/Cancer, bleeding disorders, Rheumatoid Arthritis, Psoriasis. Elwyn Specialty Care, a privately-held, pharmacist-owned company located in Garnet Valley, PA, is accredited by URAC, and the Accreditation Commission for Health Care (ACHC). For more information about Elwyn Specialty Care or Elwyn Pharmacy Group please contact us at 1-855-ELWYN-RX (359-9679) or visit us on the web at www.elwynspecialtycare.com or www.elwynpharmacygroup.com

 



THE BIOMATRIX FAMILY OF COMPANIES

BioMatrix Family of Companies